Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cancer Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global cancer diagnostics market size reached US$ 174.22 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 252.35 Billion by 2027, exhibiting a growth rate (CAGR) of 6.15% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Cancer diagnostics represent a range of assessments and procedures executed using sophisticated technologies to identify biomarkers, proteins, tumor type, location, and signs about the stage and presence of various cancerous tumors. They encompass imaging, tumor biopsy, laboratory tests, immunohistochemistry genetic testing, and endoscopic examination as standard assessments. These diagnostics methodologies are performed based on the patient condition and severity of disorders. Apart from this, cancer diagnostics help healthcare practitioners in developing a personalized treatment plan, evaluating specific antigens in a sample tissue by using antibodies, and providing better clinical outcomes through early diagnosis and care. As a result, they are widely adopted in hospitals and laboratories to examine breast, lung, melanoma, and colorectal cancer. Currently, they are mainly available in fluorescent in situ and comparative genomic hybridization technologies. 

Cancer Diagnostics Market Trends:

The increasing prevalence of cancer, owing to the rising consumption of alcoholic beverages and tobacco-based products, and the growing need for preventive, diagnostic technologies for better therapeutic effects are majorly driving the market growth. In line with this, significant enhancements in the healthcare sector and the advent of advanced oncological imaging modalities and imaging technologies to detect infections with enhanced accuracy are acting as another growth-inducing factor. Additionally, extensive investments by pharmaceutical companies to engineer cancer vaccines and novel biomarkers for the identification of potential tumor is contributing to the market growth. Moreover, the favorable initiatives being undertaken by non-governmental organizations (NGOs) and healthcare practitioners to sensitize individuals regarding the availability and benefits of early cancer diagnosis, such as instant decision-making and consequent treatment, are propelling the market growth. Other factors, such as the rapid establishment of private diagnostic centers and ongoing research and development (R&D) activities to design effective product variants with reduced treatment, hospitalization, and unavoidable intervention costs, are positively augmenting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:

  • Consumables
    • Antibodies
    • Kits and Reagents
    • Probes
    • Others
  • Instruments
    • Pathology-based Instruments
    • Imaging Instruments
    • Biopsy Instruments
       

Breakup by Technology:

  • IVD Testing
    • Polymerase Chain Reaction (PCR)
    • In Situ Hybridization (ISH)
    • Immunohistochemistry (IHC)
    • Next-generation Sequencing (NGS)
    • Microarrays
    • Flow Cytometry
    • Immunoassays
    • Others
  • Imaging
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Positron Emission Tomography (PET)
    • Mammography
    • Ultrasound
  • Biopsy Technique
     

Breakup by Application:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG (Roche Holding AG), GE HealthCare (General Electric Company), Hologic Inc., Illumina Inc., Koninklijke Philips N.V., Pfizer Inc., Qiagen N.V, Quest Diagnostics, Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Technology, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG (Roche Holding AG), GE HealthCare (General Electric Company), Hologic Inc., Illumina Inc., Koninklijke Philips N.V., Pfizer Inc., Qiagen N.V, Quest Diagnostics, Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global cancer diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cancer diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cancer diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Cancer Diagnostics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Consumables
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Antibodies
           6.1.2.2 Kits and Reagents
           6.1.2.3 Probes
           6.1.2.4 Others
        6.1.3 Market Forecast
    6.2    Instruments
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Pathology-based Instruments
           6.2.2.2 Imaging Instruments
           6.2.2.3 Biopsy Instruments
        6.2.3 Market Forecast
7    Market Breakup by Technology
    7.1    IVD Testing
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 Polymerase Chain Reaction (PCR)
           7.1.2.2 In Situ Hybridization (ISH)
           7.1.2.3 Immunohistochemistry (IHC)
           7.1.2.4 Next-generation Sequencing (NGS)
           7.1.2.5 Microarrays
           7.1.2.6 Flow Cytometry
           7.1.2.7 Immunoassays
           7.1.2.8 Others
        7.1.3 Market Forecast
    7.2    Imaging
        7.2.1 Market Trends
        7.2.2 Key Segments
           7.2.2.1 Magnetic Resonance Imaging (MRI)
           7.2.2.2 Computed Tomography (CT)
           7.2.2.3 Positron Emission Tomography (PET)
           7.2.2.4 Mammography
           7.2.2.5 Ultrasound
        7.2.3 Market Forecast
    7.3    Biopsy Technique
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Application
    8.1    Breast Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Lung Cancer
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Colorectal Cancer
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Melanoma
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Diagnostic Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Agilent Technologies Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Becton Dickinson and Company
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Bio-Rad Laboratories Inc.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    F. Hoffmann-La Roche AG (Roche Holding AG)
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 SWOT Analysis
        15.3.6    GE HealthCare (General Electric Company)
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Hologic Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Illumina Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Koninklijke Philips N.V.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Qiagen N.V
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Quest Diagnostics
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis
        15.3.13    Siemens Healthineers AG (Siemens AG)
           15.3.13.1 Company Overview
           15.3.13.2 Product Portfolio
           15.3.13.3 Financials
           15.3.13.4 SWOT Analysis
        15.3.14    Thermo Fisher Scientific Inc.
           15.3.14.1 Company Overview
           15.3.14.2 Product Portfolio
           15.3.14.3 Financials
           15.3.14.4 SWOT Analysis

List of Figures

Figure 1: Global: Cancer Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Cancer Diagnostics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cancer Diagnostics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Cancer Diagnostics Market: Breakup by Product (in %), 2021
Figure 5: Global: Cancer Diagnostics Market: Breakup by Technology (in %), 2021
Figure 6: Global: Cancer Diagnostics Market: Breakup by Application (in %), 2021
Figure 7: Global: Cancer Diagnostics Market: Breakup by End User (in %), 2021
Figure 8: Global: Cancer Diagnostics Market: Breakup by Region (in %), 2021
Figure 9: Global: Cancer Diagnostics (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Cancer Diagnostics (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Cancer Diagnostics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Cancer Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Cancer Diagnostics (IVD Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Cancer Diagnostics (IVD Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Cancer Diagnostics (Imaging) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Cancer Diagnostics (Imaging) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Cancer Diagnostics (Biopsy Technique) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Cancer Diagnostics (Biopsy Technique) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Cancer Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Cancer Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Cancer Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Cancer Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Cancer Diagnostics (Colorectal Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Cancer Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Cancer Diagnostics (Melanoma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Cancer Diagnostics (Melanoma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Cancer Diagnostics (Other Cancers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Cancer Diagnostics (Other Cancers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Cancer Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Cancer Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Cancer Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Cancer Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Cancer Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Cancer Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: North America: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: North America: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: United States: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: United States: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Canada: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Canada: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Asia-Pacific: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Asia-Pacific: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: China: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: China: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Japan: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Japan: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: India: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: India: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: South Korea: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: South Korea: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Australia: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Australia: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Indonesia: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Indonesia: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Europe: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Europe: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Germany: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Germany: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: France: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: France: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: United Kingdom: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: United Kingdom: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Italy: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Italy: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Spain: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Spain: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Russia: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Russia: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Latin America: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Latin America: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Brazil: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Brazil: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Mexico: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Mexico: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Middle East and Africa: Cancer Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Middle East and Africa: Cancer Diagnostics Market: Breakup by Country (in %), 2021
Figure 83: Middle East and Africa: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Global: Cancer Diagnostics Industry: SWOT Analysis
Figure 85: Global: Cancer Diagnostics Industry: Value Chain Analysis
Figure 86: Global: Cancer Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Diagnostics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cancer Diagnostics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Cancer Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Cancer Diagnostics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Cancer Diagnostics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Cancer Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Cancer Diagnostics Market: Competitive Structure
Table 8: Global: Cancer Diagnostics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4